NYSE:UNH 3 February 2026 - 27 February 2026

UnitedHealth shares fell about 2.5% to $282.85 in late-afternoon trading Monday, trailing a broader market decline. Investors focused on policy risk as the CMS comment deadline for 2027 Medicare Advantage payments approaches Feb. 25. Peers Humana and Elevance also dropped, while Cigna and CVS Health rose. Volume reached about 5.6 million shares.

UnitedHealth shares closed Friday up 0.02% at $290.00, then slipped 0.28% after hours. Investors are watching for Medicare Advantage policy updates, with a federal comment deadline set for Feb. 25 and a final rate decision expected by April 6. CMS projects a 0.09% average payment increase for 2027. UnitedHealth outperformed peers as Cigna, Elevance, CVS, and Humana all fell.

UnitedHealth Group closed up 3.1% at $293.19 on Friday, capping a three-day rally after a sharp January drop. U.S. markets are closed Monday for Presidents’ Day and reopen Tuesday. Investors await the final 2027 Medicare Advantage rate decision, with comments due Feb. 25 and a final announcement by April 6.

UnitedHealth shares rose 0.8% to $278.04 Tuesday after a volatile open, as investors watched Medicare Advantage payment updates and new federal scrutiny of health insurers. The Centers for Medicare & Medicaid Services projected a 0.09% average payment increase for 2027, with final rates due by April 6. House Republicans subpoenaed eight ACA insurers in a subsidy fraud probe; UnitedHealth was not named. Managed care stocks were mixed.

UnitedHealth shares closed up 3% at $276.65 Friday, rebounding after Molina Healthcare’s weak 2026 outlook rattled managed-care stocks. Centene later issued a stronger 2026 profit forecast, easing some pressure. UnitedHealth traded between $263.00 and $277.74 during the session. Investors await Humana’s results Feb. 11 and a Medicare Advantage rate decision April 6.

UnitedHealth shares rose 1.9% to $273.79 Friday, rebounding after Molina Healthcare’s weak 2026 profit outlook sent sector stocks tumbling Thursday. Mizuho cut its price target for UnitedHealth to $350 but kept an Outperform rating. Investors await the April 6 CMS decision on 2027 Medicare Advantage rates. Molina shares plunged nearly 28%, while Centene fell 5.5% and Cigna gained about 3%.

UnitedHealth shares fell 2.7% to $268.55 in premarket trading after Mizuho cut its price target to $350. The move follows regulatory scrutiny over Medicare Advantage payments and pharmacy benefit manager practices. Investors are watching the Feb. 25 CMS comment deadline and an April rate decision. Other managed-care stocks showed mixed premarket moves.

UnitedHealth Group shares fell 2.8% to $268.23 Thursday, underperforming managed-care peers after CMS proposed a 0.09% net payment increase for Medicare Advantage in 2027 and stricter risk adjustment rules. The company expects its Medicare Advantage membership to drop by up to 1.2 million next year, according to a regulatory filing.

UnitedHealth shares fell about 1.2% to $282.20 by midday Tuesday after Truist and JPMorgan cut their price targets to $370 and $389, respectively. Investors cited concerns over Medicare Advantage payment changes and rising medical costs. UnitedHealth recently projected 2026 revenue above $439 billion with adjusted earnings expected to top $17.75 per share.